Cargando…

Topographic Markers Drive Proteinopathies to Selection of Target Brain Areas at Onset in Neurodegenerative Dementias

Detalles Bibliográficos
Autor principal:	Abbate, Carlo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182099/ https://www.ncbi.nlm.nih.gov/pubmed/30344489 http://dx.doi.org/10.3389/fnagi.2018.00308

Ejemplares similares

Editorial: Translational imaging in neurodegenerative proteinopathies
por: Ni, Ruiqing, et al.
Publicado: (2022)

Editorial: Mechanisms of Action in Neurodegenerative Proteinopathies
por: Miller, Sean J., et al.
Publicado: (2022)

Chronic traumatic encephalopathy and other neurodegenerative proteinopathies
por: Tartaglia, Maria Carmela, et al.
Publicado: (2014)

Editorial: Prodromal stage of neurodegenerative proteinopathies: from bench to bedside
por: Xu, Bin, et al.
Publicado: (2023)

From clinical phenotype to proteinopathy: molecular neuroimaging in neurodegenerative dementias
por: Studart-Neto, Adalberto, et al.
Publicado: (2022)

Karyopherin abnormalities in neurodegenerative proteinopathies
por: Pasha, Terouz, et al.
Publicado: (2021)

Neurodegenerative proteinopathies associated with neuroinfections
por: Danics, Krisztina, et al.
Publicado: (2021)

Drosophila melanogaster as a model to study autophagy in neurodegenerative diseases induced by proteinopathies
por: Santarelli, Stefania, et al.
Publicado: (2023)

Moving from neurodegenerative dementias, to cognitive proteinopathies, replacing “where” by “what”…
por: Allegri, Ricardo Francisco
Publicado: (2020)

Organotypic brain slice cultures to model neurodegenerative proteinopathies
por: Croft, C. L., et al.
Publicado: (2019)

Immunotherapy Targeting Neurodegenerative Proteinopathies: α-Synucleinopathies and Tauopathies
por: Shin, Junghwan, et al.
Publicado: (2020)

Proteinopathies and OXPHOS dysfunction in neurodegenerative diseases
por: Kawamata, Hibiki, et al.
Publicado: (2017)

Ligands binding to the prion protein induce its proteolytic release with therapeutic potential in neurodegenerative proteinopathies
por: Linsenmeier, Luise, et al.
Publicado: (2021)

The neurophysiological architecture of semantic dementia: spectral dynamic causal modelling of a neurodegenerative proteinopathy
por: Benhamou, Elia, et al.
Publicado: (2020)

Correction: Proteinopathies and OXPHOS dysfunction in neurodegenerative diseases
por: Kawamata, Hibiki, et al.
Publicado: (2018)

Promiscuous Roles of Autophagy and Proteasome in Neurodegenerative Proteinopathies
por: Limanaqi, Fiona, et al.
Publicado: (2020)

Neurodegenerative diseases as proteinopathies-driven immune disorders
por: Ciccocioppo, Fausta, et al.
Publicado: (2019)

Neurodegenerative Proteinopathies in the Proteoform Spectrum—Tools and Challenges
por: Noor, Aneeqa, et al.
Publicado: (2021)

Propagation of TDP-43 proteinopathy in neurodegenerative disorders
por: Keszycki, Rachel, et al.
Publicado: (2021)

Oligomers Are Promising Targets for Drug Development in the Treatment of Proteinopathies
por: Galzitskaya, Oxana V.
Publicado: (2020)

Recent Developments in Positron Emission Tomography Tracers for Proteinopathies Imaging in Dementia
por: Ni, Ruiqing, et al.
Publicado: (2022)

Photo-Oxygenation as a New Therapeutic Strategy for Neurodegenerative Proteinopathies by Enhancing the Clearance of Amyloid Proteins
por: Tomizawa, Ikumi, et al.
Publicado: (2022)

Distinct Pattern of Microgliosis in the Olfactory Bulb of Neurodegenerative Proteinopathies
por: Kohl, Zacharias, et al.
Publicado: (2017)

Altered Mitochondrial Protein Homeostasis and Proteinopathies
por: Jishi, Aya, et al.
Publicado: (2022)

The proteomic effects of ketone bodies: implications for proteostasis and brain proteinopathies
por: García-Velázquez, Lizbeth, et al.
Publicado: (2023)

Mitochondrial dysfunction and neurodegenerative proteinopathies: mechanisms and prospects for therapeutic intervention
por: Briston, Thomas, et al.
Publicado: (2018)

Molecular mechanisms of proteinopathies across neurodegenerative disease: a review
por: Marsh, Alexander P.
Publicado: (2019)

Untangling the origin and function of granulovacuolar degeneration bodies in neurodegenerative proteinopathies
por: Wiersma, Vera I., et al.
Publicado: (2020)

TDP-43 proteinopathies: a new wave of neurodegenerative diseases
por: de Boer, Eva Maria Johanna, et al.
Publicado: (2021)

Control of mRNA Translation in ALS Proteinopathy
por: Cestra, Gianluca, et al.
Publicado: (2017)

Proteinopathy-induced neuronal senescence: a hypothesis for brain failure in Alzheimer's and other neurodegenerative diseases
por: Golde, Todd E, et al.
Publicado: (2009)

Virtual brain simulations reveal network-specific parameters in neurodegenerative dementias
por: Monteverdi, Anita, et al.
Publicado: (2023)

Mechanisms of TDP-43 Proteinopathy Onset and Propagation
por: Chen, Han-Jou, et al.
Publicado: (2021)

Brain network connectivity differs in early-onset neurodegenerative dementia
por: Filippi, Massimo, et al.
Publicado: (2017)

Revisit the Cellular Transmission and Emerging Techniques in Understanding the Mechanisms of Proteinopathies
por: Jiang, Jinwen, et al.
Publicado: (2021)

Cannabinoid CB2 Receptors in Neurodegenerative Proteinopathies: New Insights and Therapeutic Potential
por: Vuic, Barbara, et al.
Publicado: (2022)

Application of advanced brain positron emission tomography–based molecular imaging for a biological framework in neurodegenerative proteinopathies
por: Perani, Daniela, et al.
Publicado: (2019)

Editorial: The role of the cerebellum in dementia and neurodegenerative diseases
por: Toniolo, Sofia, et al.
Publicado: (2023)

Targets and mechanisms of Alpinia oxyphylla Miquel fruits in treating neurodegenerative dementia
por: Zeng, Peng, et al.
Publicado: (2022)

Generative Model of Brain Microbleeds for MRI Detection of Vascular Marker of Neurodegenerative Diseases
por: Momeni, Saba, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7roi55dkdqd14pq1e7hkftg39j